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Abstract
Epigenetic changes are involved in a wide range of common human diseases. Although DNA methylation defects are
known to be associated with male infertility in mice, their impact on human deficiency of sperm production has yet to be
determined. We have assessed the global genomic DNA methylation profiles in human infertile male patients with
spermatogenic disorders by using the Infinium Human Methylation27 BeadChip. Three populations were studied: conserved
spermatogenesis, spermatogenic failure due to germ cell maturation defects, and Sertoli cell-only syndrome samples. A
disease-associated DNA methylation profile, characterized by targeting members of the PIWI-associated RNA (piRNA)
processing machinery, was obtained. Bisulfite genomic sequencing and pyrosequencing in a large cohort (n = 46) of
samples validated the altered DNA methylation patterns observed in piRNA-processing genes. In particular, male infertility
was associated with the promoter hypermethylation-associated silencing of PIWIL2 and TDRD1. The downstream effects
mediated by the epigenetic inactivation of the PIWI pathway genes were a defective production of piRNAs and a
hypomethylation of the LINE-1 repetitive sequence in the affected patients. Overall, our data suggest that DNA methylation,
at least that affecting PIWIL2/TDRD1, has a role in the control of gene expression in spermatogenesis and its imbalance
contributes to an unsuccessful germ cell development that might explain a group of male infertility disorders.
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Introduction
Genetic etiologies have only been able to explain about 15% of
cases of male infertility [1]. Approximately 4% of men suffer from
infertility, with 70% of cases of testicular origin being a
consequence of a spermatogenic failure. At least 30% of infertile
men suffer from idiopathic infertility of unknown underlying
pathophysiology. Mammalian spermatogenesis is a complex and
highly regulated developmental process in which mitosis, meiosis
and differentiation interact to coordinate the development of a
haploid gamete for sexual reproduction. These processes are
unique in male germ cell differentiation and depend on precise
developmental stage-specific and germ cell type-specific gene
expression. Changes in testicular gene expression have been found
in spermatogenic failure [2–7]. However, the regulatory network
that controls germline transcription in mammals is not properly
understood. In this context, it has been suggested that DNA
methylation may contribute to the control of gene expression
programs essential for successful gametogenesis [8].
DNA methylation is an epigenetic process that plays a crucial
role in determining the time point and magnitude of gene
expression. Unlike the genetic code, the epigenetic code is
dynamic and tissue-specific [9]. While the genetic code defines a
permanent blueprint of information determining phenotypes and
specific traits, the epigenetic code provides a dynamic signalling
that is capable of modifying phenotypes according to environ-
mental impacts. Epigenetic regulation is a crucial mechanism for
cell fate and survival [10,11]. In particular, DNA methylation is
involved in a wide range of common human diseases [12–15].
Within male germ cells, changes in the epigenetic state are critical
for silencing transposable elements, imprinting paternal genes,
several aspects of meiosis, post-meiotic gene silencing and DNA
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compaction. Recombinant mouse models identified a profound
impact of DNA methylation processing enzymes (DNA methyl-
transferases, DNMTs) on sperm production. Expression changes
of DNMTs in germline stem cells lead to aberrant survival and
differentiation [16]. Particularly, a defective DNMT3L results in
meiotic failure and impaired spermatogenesis [17]. In addition,
DNMT3b mutants reveal a delayed entry into meiosis, resulting in
a greatly reduced number of spermatocytes [18].
Abnormal sperm DNA methylation of imprinted genes is
associated with spermatogenic impairment [19–21], and DNA
methylation abnormalities may also involve non-imprinted genes
[22]. In this context, it is tempting to speculate that male infertility
could be linked to epigenetic alterations, such as abnormal DNA
methylation patterns.
It is currently unclear whether DNA methylomes of men with
impaired sperm production significantly differ from those
presenting a complete and efficient spermatogenic process. To
address this matter, we analyzed genome-wide DNA methylation
in infertile men with spermatogenic failure. Using the Infinium
Human Methylation27 BeadChip technology [23,24], we ob-
tained an insight into the impact of DNA methylation in secretory
male infertility. Among the nearly 600 genes differentially
methylated in testis with impaired spermatogenesis compared
with tissue with a conserved spermatogenic pattern, we focused on
those coding for proteins directly involved in piRNA processing
[PIWIL1 [25]; PIWIL2 [26]] and associated molecules [TDRD1




Our study recruited thirty-two infertile patients (aged 30–49
years) due to severe spermatogenic failure (SpF), with a phenotype
consistent with non-obstructive (secretory) azoospermia or severe
oligozoospermia (,5 million sperm/ml). Only testicular samples
with homogeneous phenotypes were selected on the basis of the
histological pattern of .20 tubules from the same testicular
section; samples with mixed histological patterns were excluded
from the study. In addition, five patients with a Sertoli cell-only
syndrome (SCO) phenotype were studied as methylation/gene
expression controls of somatic cells and nine infertile patients (aged
32–50 years), who were diagnosed with obstructive azoospermia
(as a consequence of congenital absence of the vas deferens or a
previous vasectomy) and showed conserved spermatogenesis (CS)
were studied as methylation/gene expression controls of a
complete spermatogenic process (Table 1). Infertile individuals
were selected from men referred for couple infertility to the
Andrology Service of the Fundació Puigvert. The study was
approved by the Institutional Review Board of the Center, and all
the participants gave their informed written consent to the
procedures of the study.
The clinical procedures for infertile patients included medical
history, physical examination, semen analyses (performed in
accordance with World Health Organization guidelines [30])
and hormonal study. Concentrations of FSH generally reflected
the findings of the testicular histology, although some patients
showing primary spermatocyte arrest or hypospermatogenesis had
normal FSH (data not shown). Spermiograms included volume,
pH, sperm concentration, motility, vitality, morphology and
fructose and citrate levels in seminal plasma. The testicular biopsy
was obtained when necessary to confirm the clinical diagnosis and
for sperm retrieval (TESE) and cryopreservation purposes.
The routine genetic study for all non-obstructive samples
included karyotype and analysis of chromosome Y microdeletions,
the latter performed according to the European guidelines [31,32].
Men with a chromosomal aberration or a Y-chromosome
microdeletion were not included in the study.
Testicular Samples
Testicular biopsies of infertile men were obtained under local
anesthesia through a small incision. Each specimen was divided
into three aliquots, one piece (<10–20 mg) was fixed in Bouin’s
solution and reserved for histological analysis, a second aliquot
(<100–200 mg) processed for sperm extraction, and the third
(<10 mg) was immediately transferred to liquid nitrogen and then
stored at –80uC until used for molecular analysis.
Histological Analysis
Fixed testicular biopsies were cut into 5-mm sections and stained
with hematoxylin–eosin. Germ cells of the different levels of
maturation (spermatogoniae, spermatocytes I, round spermatids
and elongated spermatids) and Sertoli cells were quantified, and
the average number per tubule was calculated after analysis of at
least 15–20 cross-sectioned tubules/testis. Assessment of the
spermatogenic status and the severity of the alteration is shown
by a modified Johnsen score (JS) [33], calculated on the basis of the
number of different cell types per tubule.
Using this strategy we confirmed the diagnosis of SCO and CS
phenotypes. With respect to SpF patients, eight of them presented
maturation failure at the round spermatid level (rsMF), fifteen at
the spermatocyte level (scMF) and nine at the spermatogonia level
(sgMF), due to the presence of a diminished number of this specific
stage and the subsequent germ cell stages in their tubules
compared with CS samples (Table 1).
Spermatozoa Isolation and DNA Extraction
Semen samples obtained from normozoospermic men were
collected and allowed to liquefy for 30 min. Before the standard
swim-up separation technique, whole semen was centrifuged on a
25% Percoll gradient (20 minutes) to discard somatic cell
contamination, further ensuring the purity of the sperm popula-
tion. The swim-up procedure results in selection of spermatozoa
with good motility.
Sperm DNA was extracted with an user-developed version of
the QIAampH DNeasy&Tissue Kit purification protocol (Qiagen).
Fresh washed (in PBS) sperm was incubated 1:1 with a lysis buffer
containing 20 mM TrisCl (pH 8), 20 mM EDTA, 200 mM NaCl
and 4% SDS, supplemented prior to use with 100 mM DTT and
250 ug/ml Proteinase K. Incubation was performed for 4 hours at
55uC with frequent vortexing. Prior to processing in the columns,
200 ul of absolute ethanol and 200 ul of the kit-provided lysis
buffer were added to the samples. Then, purification was
performed according to kit instructions.
DNA Methylation-specific Array
Genomic DNA was extracted from testicular biopsies by using
the Wizard Genomic DNA Purification kit (Promega, Madison,
USA). DNA methylation profile was assessed using the Infinium
Human Methylation27 BeadChip (Illumina, San Diego, USA),
which assays DNA methylation levels at 27,578 CpG sites. Briefly,
DNA was quantified by Quant-iTTM PicoGreen dsDNA Reagent
(Invitrogen, Carlsbad, USA) and the integrity was analyzed in a
1.3% agarose gel. Bisulfite conversion of 600 ng of each sample,
which results in unmethylated cytosines being converted to uracils,
whereas methylated cytosines are not converted, was performed
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1 OA CS 0 202.5 25.7 43.6 33.2 26.5 15.3 9.85
2 OA CS 0 186.7 21.4 28.1 31.3 24.8 9.1 9.70
3 OA CS 0 200.0 23.6 28.8 30.5 28.3 15.9 9.62
4 OA CS 0 190.0 20.7 33.7 38.5 33.1 13.5 9.55
5 OA CS 0 200.0 26.7 28.2 20.3 21.1 13.9 9.30
6 OA CS 0.02 206.0 25.8 31.8 29.6 21.4 13.1 9.25
7 OA CS 0.1 229.6 22.8 28.5 16.6 16.0 14.2 9.00
8 OA CS 0 195.0 20.7 30.5 31.9 12.8 11.5 8.70
9 OA CS 0 184.0 14.8 29.8 12.5 22.3 8.4 8.65
Mean 199.3 22.5 31.4 27.2 22.9 12.8
10 SA SpF (rsMF) 0 200.0 23.4 36.0 19.7 10.1 12.2 8.40
11 SSO SpF (rsMF) 5 151.7 15.0 27.6 15.5 9.8 11.3 8.40
12 SSO SpF (rsMF) 0.01 188.0 18.5 33.5 20.4 6.7 19.0 8.30
13 SA SpF (rsMF) 0.004 191.5 25.1 36.2 19.6 0.7 18.6 7.10
14 SSO + OA SpF (rsMF) 0 175.0 17.0 24.0 31.0 1.5 6.0 7.00
15 SSO SpF (rsMF) 3.5 170.0 13.0 20.0 15.0 1.5 11.0 7.00
16 SSO SpF (rsMF) 5 205.0 20.2 28.6 15.7 0.1 23.3 6.60
17 SSO SpF (rsMF) 3 148.8 19.7 22.3 15.4 0.3 18.4 6.50
Mean 178.8 19.0 28.5 19.0 3.8 15.0
18 SA + OA SpF (scMF) 0 200.6 19.5 22.9 5.6 6.9 15.7 7.10
19 SA SpF (scMF) 0 168.3 20.4 18.2 5.3 3.1 13.4 7.30
20 SSO SpF (scMF) 5 181.9 17.1 18.1 10.8 4.1 9.2 7.65
21 SSO SpF (scMF) 9 216.9 20.8 25.0 4.1 3.0 17.4 6.71
22 SSO SpF (scMF) 0.8 193.1 13.1 17.2 5.8 2.1 16.7 6.90
23 SA SpF (scMF) 0 170.0 19.5 17.6 4.0 2.1 14.1 6.70
24 SA SpF (scMF) 0.005 156.9 17.9 21.6 4.2 1.2 8.6 5.80
25 SSO SpF (scMF) 0.4 196.8 24.8 21.1 1.9 0.5 11.8 5.20
26 SA SpF (scMF) 0 190.0 23.0 30.0 0.0 0.0 11.0 5.00
27 SA SpF (scMF) 0 190.0 17.6 18.2 0.0 0.0 20.0 5.00
28 SA SpF (scMF) 0 190.0 22.5 39.6 0.0 0.0 16.0 5.00
29 SA SpF (scMF) 0 168.3 15.1 12.5 2.3 1.7 12.2 6.90
30 SA SpF (scMF) 0 175.0 15.9 10.8 0.0 0.0 10.1 4.73
31 SSO SpF (scMF) 0.5 191.0 18.8 6.6 2.0 1.3 12.8 5.75
32 SSO SpF (scMF) 0.015 190.0 23.0 6.0 5.0 5.0 11.0 4.40
Mean 185.3 19.3 19.0 3.4 2.1 13.3
33 SA SpF (sgMF ) 0.009 166.7 12.7 23.1 18.7 10.6 15.3 8.10
34 SSO SpF (sgMF ) 0.02 148.3 10.8 17.8 7.4 10.2 7.4 6.80
35 SSO SpF (sgMF ) 0.1 164.2 12.0 14.0 9.1 8.0 7.6 6.75
36 SA SpF (sgMF ) 0 171.9 13.1 15.7 10.7 10.9 16.0 5.40
37 SSO SpF (sgMF ) 0.6 136.3 6.0 6.7 1.7 0.2 6.5 4.50
38 SA SpF (sgMF ) 0 153.1 8.3 12.6 0.0 0.0 6.6 3.45
39 SA SpF (sgMF ) 0 97.5 8.5 0.2 0.0 0.0 5.2 2.80
40 SA SpF (sgMF ) 0 115.0 2.8 2.3 0.2 0.0 7.7 3.80
41 SSO SpF (sgMF ) 0.8 156.2 1.1 1.2 1.8 1.8 28.1 2.40
Mean 145.5 8.3 10.4 5.5 4.6 11.1
42 SA SCO 0 163.3 0.0 0.0 0.0 0.0 28.5 2.00
43 SA + OA SCO 0 170.0 0.0 0.0 0.0 0.0 17.0 2.00
44 SA SCO 0 165.0 0.0 0.0 0.0 0.0 19.5 2.00
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according to the manufacturer’s recommendation for the Illumina
Infinium Assay. Effective bisulfite conversion was checked for
three controls that were converted simultaneously with the
samples. The intensities of the images were extracted and
normalized using GenomeStudio (V2010.3, Illumina) software.
The methylation score of each CpG was represented as a beta (b)
value. The threshold for concluding differential methylation of
probes was set at an average delta b value .0.1.
Bisulfite Sequencing
Genomic DNA was bisulfite-modified using the EZ DNA
Methylation-Gold Kit (Zymo Research, Orange, USA) according
to the manufacturer’s protocol. The methylation status of selected
regions was analyzed by bisulfite genomic sequencing. Bisulfite-
converted DNA was amplified (Table S1) and subsequently cloned
using the pGEM-t easy kit (Promega, Madison, USA). At least
eight independent clones were analyzed in an automated ABI
Prism 3700 sequencer (Applied Biosystems, Carlsbad, USA).
Pyrosequencing
Amplification primers (Table S1) and sequencing settings were
designed using a PyroMark assay design (V2.0.01.15; Qiagen).
LINE-1 was quantified using the PyroMark Q96 LINE-1 assay
(Qiagen). PCR was performed with primers biotinylated to convert
the PCR product to single-stranded DNA templates. The Vacuum
Prep Tool (Biotage, Uppsala, Sweden) was used to prepare single-
stranded PCR products according to the manufacturer’s instruc-
tions. Pyrosequencing reactions and methylation quantification
were performed using the PyroMark Q96 System (Qiagen).
Gene Expression Quantification
Total RNA was obtained from the testicular biopsy using the
Absolutely RNA Miniprep Kit (Stratagene, La Jolla, CA),
according to the instructions provided by the manufacturer.
Furthermore, small RNA-containing total RNA was additionally
obtained with a mirVana miRNA Isolation Kit (Ambion) from an
extra portion of the testicular biopsy whenever this was possible.
The quality of RNA was assessed using the Agilent 2100
Bioanalyzer (Agilent Technologies, Waldbronn, Germany). Tes-
ticular RNA samples included in the study had a 28S/18S ratio
.1.3 and an RIN value .7.5. Single-stranded cDNA was
obtained by reverse transcription (RT) of 500 ng of RNA using
random hexamer primers and the High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems).
Quantitative real-time PCR (qPCR) reactions were performed
on an ABI 7300 real-time PCR system (Applied Biosystems) using
gene-specific TaqMan Assays (PIWIL2: Hs00216263_m1;
TDRD1: Hs00229805_m1; PGM1: Hs00160062_m1) and cus-
tom-designed small RNA TaqMan Assays (Applied Biosystems).
Negative controls without template were included in each set of
PCR assays as well as a calibrator sample to compare the change
in expression of a nucleic acid sequence against the expression in
all samples in the same study. PGM1 was previously selected as an
appropriate reference gene among ten candidate genes tested (data
not shown) for PIWIL2 and TDRD1 data normalization in our
study, showing similar Ct values to the ones obtained from target
genes, no statistical differences in expression among group-
s_(Kruskal-Wallis test) and low M-value (GeNorm software; [34])
indicating stable expression among samples. For piRNA expres-
sion analysis the arithmetic mean value of Ct values of RNU48,
RNU19 and RNU6B was used for normalization.
Patient and control group samples were always analyzed as
paired samples in the same analytical run in order to exclude
between-run variations. Real-time qPCR data were pre-processed
using the 22DDCt strategy and stored in SDS 2.1 software (Applied
Biosystems). Expression levels are shown as relative quantification
(RQ) values.
Statistical Analysis
Statistical analyses were performed using SPSS 12.0 software
(SPSS Inc, Chicago, Illinois). The nonparametric Mann-Whitney
U test was used to analyze differences in absolute expression and
methylation level in SpF patient groups compared with controls.
Pearson product-moment correlation coefficients were calculated
to determine the correlation between the methylation status,
expression ratios of the target genes and the various histological
parameters in patient groups and controls. A value of p,0.05 was
considered significant. Gene Ontology (GO), pathways enrich-
ment analysis was performed using the Database for Annotation,
Visualization and Integrated Discovery (DAVID; v6.7).
piRNA Target Identification
The complete set of piRNA sequences was obtained from
piRNA bank (http://pirnabank.ibab.ac.in) and aligned (BLAT) to
the reference genome. Subsequently, the promoter regions
(transcription start site +/22 kb) of the 580 differentially
methylated genes were analyzed for the presence of piRNA
complementarity. Promoters with sequence identity of 100% to


















45 SA SCO 0 165.0 0.0 0.0 0.0 0.0 20.7 2.00
46 SA SCO 0 165.0 0.0 0.0 0.0 0.0 19.1 2.00
Mean 165.6 0.0 0.0 0.0 0.0 21.0
Abbreviations: conc., concentration; CS, conserved spermatogenesis; OA, obstructive azoospermia; SA, secretory azoospermia; SCO, Sertoli.
cell only syndrome; Spcyte, spermatocyte; SpF, spermatogenic failure; Spgonia, spermatogonia; Sptid, spermatid; SSO, severe secretory.
oligozoospermia; sgMF, maturation failure at spermatogonia level; scMF, maturation failure at spermatocyte level; rsMF, maturation failure at round.
spermatid level.
(a)The mean number of the different type of cells per tubule is given in each group.
doi:10.1371/journal.pone.0047892.t001
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Results
DNA Methylation Profiles Distinguish Male Infertility
Disorders from Physiological Germ Cell Development
In order to identify the genome-wide DNA methylation changes
associated with severe germ cell development deficiencies in the
testis we used a DNA methylation bead-assay covering
27,578 CpG sites in the genome [23,24,35]. As the probes are
almost exclusively located in promoter regions, the array gives a
comprehensive overview of 14,495 individual genes. The repro-
ducibility and sensitivity of the array has been described elsewhere
[23,24,35]. Using this platform, we analyzed the methylation
profile of testis with conserved spermatogenesis (CS) (n = 2),
spermatogenic failure (SpF) samples (two of them -sample no. 25
and 28- presented maturation failure at the spermatocyte level
[scMF] and two -sample nos. 10 and 13- at the round spermatid
level [rsMF]) and Sertoli cell-only syndrome patients (SCO)
(n = 2), the latter completely lacking germ cells in the testicular
tubules. CS and SpF samples show similar numbers of
spermatogoniae and spermatocytes in the tubule (Table 1).
Comparing all CG sites interrogated by the array platform, SpF
samples had a highly similar profile to the CScontrol (r2 = 0.99).
However, unsupervised hierarchical clustering revealed a distinct
methylation profile of the three SpF patient samples that entirely
lacked elongated spermatids, unlike the CS controls (samples
no. 13, 25 and 28; Table 1). Furthermore, the methylation profile
of the SpF sample no. 10 was clustered with the CS control
samples (Fig. 1A). The SCO specimens had highly variable
Figure 1. DNA methylation microarray analysis determined disease-associated profiles. (A) Unsupervised hierarchical clustering
separated testis with a complete absence of germ cells (SCO) from those with the presence of germ cell lineage, and testis with conserved
spermatogenesis (CS) from those with spermatogenic failure (SpF) human samples. (B) Hierarchical clustering of CS, SpF and SCO samples, displaying
the 633 CpG sites differentially methylated between CS and SpF samples. (C) Hierarchical clustering of PIWIL1/2 and TDRD1/9 involved in the piRNA
processing machinery. Sample number corresponding to that in Table 1 is also indicated.
doi:10.1371/journal.pone.0047892.g001
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methylation levels compared with the other groups, reflecting the
somatic origin of the Sertoli cells and the specific methylation
patterns of germline and somatic tissues. We were also able to
identify 633 differentially methylated sites (DMSs; average delta b
value .0.1) (327 hypomethylated and 306 hypermethylated) in the
three clustered SpF samples relative to the CS control tissue,
representing 580 different genes (comprises 4% of the tested genes)
(Fig. 1B, Table S2). Interestingly, while most of the probes present
on the array were located in CpG islands (73%), the DMSs
identified were significantly enriched in CpG-poor promoters
(64%; Chi-square test, p,0.01). From a biological ontology point
of view, hypermethylated genes are enriched in functions directly
related to germline processes, such as germline stem-cell mainte-
nance (Fisher’s exact test, p = 1.661024), reproductive cellular
process (Fisher’s exact test, p = 0.018) and gamete generation
(Fisher’s exact test, p = 0.03) (Table S3). In particular, hyper-
methylation of PIWIL1, PIWIL2, SPATA16, MSH4, INSL3,
CNGA1, FANCG and HIST1H1T contributed to the enrichment
in the biological process of male gamete generation. Furthermore,
other germline-specific genes such as PAGE1 and XAGE3/5 were
found to be differentially methylated in SpF patient samples
relative to CS (Table S2).
It is of particular note that genes involved in the biogenesis of
PIWI-associated RNAs (piRNAs), such as the differentially
methylated in the array PIWIL1/2 and their associated molecules
TDRD1/9, were able to cluster normal tissue and patient samples
(including sample no.10) separately, suggesting that hypermethyla-
tion of these genes is a disease-associated event (Fig. 1C).
Promoter Hypermethylation-associated Transcriptional
Silencing of PIWIL2 and TDRD1 in Infertile Males with
Spermatogenic Failure
The disruption of genes associated with the piRNA processing
machinery has been directly related to spermatogenic failure due
to maturation arrest, resulting in male sterility in mouse models.
As genome-wide analysis of patient samples with spermatogenic
failure identified deregulation of genes involved in piRNA
production, we aimed to validate these genes in a larger cohort
of samples. To assess the impact of DNA methylation on genes
involved in the piRNA processing machinery, we performed
bisulfite genomic sequencing of the promoter regions of PIWIL1/2
and TDRD1/9 in three CS samples, six SpF samples (three rsMF
and three scMF) and three SCO samples (Fig. 2 and Fig. S1 and
S2). Differences in DNA methylation between SpF and CS
samples were observed in all the genes analyzed, the magnitude
being most striking for PIWIL2 and TDRD1. Both genes displayed
minimal or no promoter methylation in CS normal tissue and a
great increase in rsMF (Student’s t test ,0.05) samples. TDRD9
also exhibited an elevated level of methylation, although we had
already detected increased levels in normal tissue. This was even
more evident for PIWIL1, for which half of the CpG sites analyzed
were found to be methylated in CS samples. As expected, we
observed striking differences between CS testis tissue and SCO
samples, which is consistent with the germline-specific expression
associated with the analyzed genes. Here, hypermethylation was
detected in all five genes, probably due to the total absence of
germ cells, in SCO specimens.
Figure 2. PIWIL2 and TDRD1 become more methylated in human infertility syndromes. Bisulfite sequencing of the piRNA processing genes
PIWIL1 (A), PIWIL2 (B), TDRD1 (C) and TDRD9 (D). Black and white squares indicate CpG methylation and unmethylated sites, respectively. One
representative sample of a large difference between testis with conserved spermatogenesis (CS), maturation failure at the spermatocyte (scMF) or at
the round spermatid (rsMF) stage, and in Sertoli cell-only syndrome (SCO) are displayed. Sample number corresponding to that in Table 1 is also
indicated. (E) Methylation level of gene promoters of PIWIL1, PIWIL2, TDRD1 and TDRD9 in testis with conserved spermatogenesis (CS), maturation
failure at the spermatocyte (scMF) or at the round spermatid (rsMF) stage, and in Sertoli cell-only syndrome (SCO) samples. Independent data are also
shown in Figure S1 and S2. Significant differences compared to CS samples are indicated (*).
doi:10.1371/journal.pone.0047892.g002
PIWI Defects in Infertility
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To confirm the hypermethylation of PIWIL2 and TDRD1 in
SpF-affected patients, locus-specific pyrosequencing was per-
formed in a larger validation patient cohort. In detail, nine
normal CS control, thirty-two SpF (rsMF, scMF, sgMF) affected
patient samples and five SCO specimens were analyzed to detect
the CpG site immediately upstream of the transcription start site.
To gain a better insight into the tissue specificity of PIWIL2 and
TDRD1, we also included five samples from mature swim up-
selected spermatozoa and six somatic tissues from colon, breast,
blood, skin, lung and brain in the study. As expected, spermatozoa
exhibited an absence of DNA methylation in both genes, whereas
both promoters were heavily methylated in all somatic tissues
(Fig. 3A and B). In SpF samples, we were able to validate a
significant increase in promoter methylation (Mann-Whitney test,
p,0.01) of PIWIL2 and TDRD1 (Fig. 3A and B). It is of note that
SCO samples and somatic tissues had similar TDRD1 DNA
methylation levels, whereas PIWIL2 methylation is reduced in
SCO when compared to somatic tissues (Mann-Whitney test,
p = 0.015; Fig. 3A and 3B). Furthermore, to have a better insight
into methylation level related to the testicular sample cell
composition, PIWIL2 and TDRD1 methylation data was first
divided by the proportion of somatic cells per tubule (Fig. 3C and
D). The number of somatic cells was inferred from the number of
Sertoli cells quantified per tubule in each testicular sample, as the
Sertoli cells represent the 30% of somatic cells related to one
testicular tubule. As no SpF sample was observed to present
hyperplasia of Leydig cells it is assumed that the somatic cell
number was constant among CS and SpF samples. We observed
no statistical difference in methylation per somatic cell among the
different subgroups of the study. Additionally PIWIL2 and TDRD1
methylation data was divided by the proportion of germ cells per
tubule obtaining a hypermethylation profile, being more consid-
erable as the maturation failure affects an earlier germline stage
(CS,rsMF,scMF,sgMF; Mann-Whitney test p,0.001; Fig. 3E
and F). Altogether this analysis suggest that the changes in the
tissular methylation pattern observed in SpF samples could not be
exclusively explained by the proportion of somatic cells in the
testicular sample but it is the result of the sum of the increased
proportion of somatic cells and, also, of the increase of individual
methylation of germ cells.
Most importantly, the hypermethylation observed in patients
was accompanied by reduced transcript levels (Fig. 4A and B).
Both genes had significantly less transcript in the SpF patient
samples than in the CS control tissue (Mann-Whitney test,
p,0.01). Strikingly, tissular gene methylation and expression level
were highly significantly and negatively correlated for PIWIL2
Figure 3. SpF samples show a PIWIL2 and TDRD1 hypermethylation pattern. Methylation levels of PIWIL2 (A) and TDRD1 (B) in mature
spermatozoa (sperm), testis with a conserved spermatogenic pattern (CS), maturation failure at the round spermatid (rsMF), the spermatocyte (scMF)
and the spermatogonia (sgMF) stages, Sertoli cell-only syndrome (SCO) and somatic tissue measured by pyrosequencing. The black bar indicates the
mean methylation level. Methylation per cell profiling of PIWIL2 and TDRD1, displayed as methylation per somatic cell (x100) (C, D) and methylation
per germ cell (x100) (E, F) in testis with conserved spermatogenesis (CS), maturation failure at the round spermatid (rsMF), the spermatocyte (scMF)
and the spermatogonia (sgMF) stages and Sertoli cell-only syndrome (SCO). The horizontal bar displays the mean cellular expression level. Significant
differences from the control are indicated: *p,0.05; **p,0.01.
doi:10.1371/journal.pone.0047892.g003
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(Pearson’s correlation, r = 20.74; p,0.0001) and TDRD1 (Pear-
son’s correlation, r = 20.76; p,0.0001). We additionally analyzed
the germ cell–specific transcript levels per cell in SpF subgroups
compared to CS controls in order to exclude the differences in
gene expression due to changes in testicular cellularity and to
determine whether transcript level per cell is also altered in SpF.
Values of transcript amount per cell, in arbitrary units, were
obtained for each testicular sample by dividing the PIWIL2/
TDRD1 expression values by the proportion of expressing germ
cell stages present in a seminiferous tubule of the sample, being
spermatogoniae and primary spermatocytes the germ cell stages
that predominantly express PIWIL2, whereas spermatocytes
predominantly express TDRD1 in the testis (GermSAGE;
http://germsage.nichd.nih.gov) (Fig. 4C and D). Significant
differences in cellular transcript levels were found for both genes
between SpF patients and controls (Mann-Whitney test, p,0.01).
Interestingly, the expression level per cell and the gene
methylation were also highly significantly and negatively correlat-
Figure 4. PIWIL2 and TDRD1 hypermethylation is negatively associated with PIWIL2 and TDRD1 transcript levels in SpF samples.
Tissular expression profiling of PIWIL2 (A) and TDRD1 (B) by quantitative real-time qPCR in testis with conserved spermatogenesis (CS), maturation
failure at the round spermatid (rsMF), the spermatocyte (scMF) and the spermatogonia (sgMF) stages and Sertoli cell-only syndrome (SCO). Expression
levels relative to PGM1 are shown. Expression per cell profiling of PIWIL2, displayed as expression ratio per spermatogonia/spermatocyte (x1000) (C)
and expression per cell of TDRD1, displayed as expression ratio per spermatocyte (X1000) (D) in testis with conserved spermatogenesis (CS),
maturation failure at the spermatocyte (scMF), the round spermatid (rsMF), and the spermatogonia (sgMF) stages. The horizontal bar displays the
mean cellular expression level. Significant differences from the control are indicated: *p,0.05; **p,0.01.
doi:10.1371/journal.pone.0047892.g004
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ed for PIWIL2 (Pearson’s correlation, r = 20.70; p,0.0001) and
TDRD1 (Pearson’s correlation, r = 20.62; p,0.0001).
In order to assess whether there was an association between
molecular and histological data and to confirm any physiological
relevance, using all the samples in the study, we calculated the
correlations between the normalized gene expression values,
pyrosequencing data and histological parameters such as the
number of each type of cell from the germline, Sertoli cell number
and JS count (Table 2). All the histological parameters, with the
exception of the Sertoli cell number, were positively correlated
with PIWIL2 and TDRD1 expression values, being remarkable the
correlation coefficient between the cellular transcript levels of
PIWIL2 and the number of elongated spermatids in the tubule
(r = 0.82; p,0.0001), whilst a negative correlation coefficient was
obtained with their DNA methylation levels.
Defects in the Establishment of piRNA-directed DNA
Methylation Patterns in Impaired Sperm Production
We examined the potential consequences of PIWIL2 and
TDRD1 repression in patient samples with spermatogenic defects.
First, we determined the expression of five primary piRNAs with
strictly restricted germline expression [36] (piRNABank accession
no. DQ601291, DQ591415, DQ601609, DQ589977, DQ598918)
in five normal CS control, ten SpF (rsMF n = 3, scMF n = 7)
affected SpF samples and four SCO specimens. Consistently with
the somatic origin, minimal or absent expression of the analyzed
piRNAs was observed in SCO samples (Fig. 5A–E). All piRNAs
were downregulated in SpF samples relative to CS and were
directly and inversely correlated with PIWIL2/TDRD1 expression
(range of Pearson’s correlation, r = 0.652–0.782; p,0.01) and
DNA methylation (range of Pearson’s correlation, r = 20.595–
20.767; p,0.01), respectively, as well as with the severity of
spermatogenic impairment measured as the JS value (range of
Pearson’s correlation, r = 0.643–0.756; p,0.001). Remarkably,
expression of DQ601291, DQ591415 and DQ601609 was
abolished in those samples with complete meiotic arrest (samples
no. 26 and 27) suggesting that they were postmeiotic piRNAs and
that the absence of expression might be at least partially due to the
loss of postmeiotic germ cells. However, this was not the case for
DQ589977 and DQ598918: they had a moderate level of
expression in samples with meiotic arrest, suggesting a premeiotic
expression of these piRNAs. Thus, we additionally analyzed the
germ cell–specific levels of both piRNAs (DQ589977 and
DQ598918) per cell in SpF samples compared to CS controls in
order to obviate the differences in piRNA expression due to
changes in tissular germ cell composition. Transcript levels per
cell, in arbitrary units, were obtained for each testicular sample by
dividing the piRNA expression value by the proportion of
spermatogoniae and primary spermatocytes present in a seminif-
erous tubule of the sample. Interestingly, piRNA expression per
cell positively correlated with PIWIL2/TDRD1 expression (range
of Pearson’s correlation, r = 0.660–0.748; p,0.01), PIWIL2/
TDRD1 expression per cell (range of Pearson’s correlation,
r = 0.663–0.711; p,0.01) and the severity of spermatogenic
impairment measured as the JS value (range of Pearson’s
correlation, r = 0.602–0.714; p,0.001). Negative correlation was
observed between piRNA expression per cell and DNA methyl-
ation (range of Pearson’s correlation, r = 20.553–20.696;
p,0.01).
PIWI/piRNAs complexes were shown to methylate DNA to
silence transposons in male germline stem cells. Thus, as the
piRNA-related machinery is directly involved in the regulation of
repetitive elements, we profiled the methylation status of LINE-1.
In accordance with the repression of PIWIL2 and TDRD1, we
observed hypomethylation of LINE-1 sequences using pyrose-
quencing technology in five out of the thirty-two patients suffering
spermatogenetic failure (Fig. 5F), three of whom were scMF and
two sgMF (sample nos. 21, 23, 24, 35 and 39).
In addition to repetitive elements, piRNAs also showed the
ability to guide DNA methylation and thereby regulate the
expression of protein-coding and non-coding genes. In order to
identify the DNA methylation changes of potential piRNA target
genes associated with spermatogenic failure, we screened the
promoter regions (transcription start site +/22 kb) of the 580
genes differentially methylated in SpF for sequence overlap with
piRNAs. We identified seven genes that were differentially
methylated between normal and patient samples and also found
complementarity to piRNAs sequences within their promoter
(Table S4), which implies that they might be directly targeted by
piRNA-mediated regulation. In detail, interleukin 16 (IL16),
kallikrein 1 (KLK1), G protein-coupled receptor 156 (GPR156),
histone cluster 1 H2aa (HIST1H2AA), RAB24, member RAS
oncogene family (RAB24), sphingomyelin phosphodiesterase 3
(SMPD3) and dolichyl-phosphate mannosyltransferase polypeptide



















RQ PIWIL2 0.613 p,0.0001 0.683 p,0.0001 0.541 p,0.0001 0.674 p,0.0001 20.266
p = 0.097
0.724 p,0.0001 0.711 p,0.0001
RQ TDRD1 0.666 p,0.0001 0.766 p,0.0001 0.597 p,0.0001 0.635 p,0.0001 20.208
p = 0.198
0.774 p,0.0001 0.734 p,0.0001
RQ PIWIL2/cell 0.566 p,0.0001 0.667 p,0.0001 0.677 p,0.0001 0.819 p,0.0001 20.216
p = 0.181
0.788 p,0.0001 0.764 p,0.0001
RQ TDRD1/cell 0.641 p,0.0001 0.595 p,0.0001 0.649 p,0.0001 0.732 p,0.0001 20.273
p = 0.088
0.749 p,0.0001 0.700 p,0.0001
Significant differences are indicated in bold.
doi:10.1371/journal.pone.0047892.t002
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1 (DPM1) showed piRNA sequence identity in their promoter
region, suggesting an association of piRNA deregulation with the
promoter methylation and gene expression.
Discussion
Although, several studies have reported the impact of an
aberrant DNA methylation [16–18,37] on spermatogenesis and
fertility in mouse model systems, so far none of this knowledge has
been transferred to impaired sperm production in humans.
Consequently, we investigated the methylation profiles, especially
of piRNA-associated proteins, and their potential consequences in
defective human spermatogenesis.
We screened for global DNA methylation changes in diseased
specimens using an array technology capable of profiling the DNA
methylation level of 14,495 genes. It has been described that
although the vast majority of methylation acquisition in male germ
cells is completed in primordial germ cells, before birth, changes of
DNA methylation continue to occur at a reduced number of CpGs
during spermatogenesis before pachytene [38]. In order to
distinguish SpF-associated differences in DNA methylation from
physiological spermatogenic process, we selected samples that had
similar number of cells from the earliest stages of the germline.
With this strategy, not only did we detect more than 600
differentially methylated CpG sites, which allowed us to separate
CS and SpF samples, but also we identified that the affected
promoters were enriched in genes involved in germline function
and spermatogenesis, suggesting that gene repression by hyper-
methylation of germline specific genes is probably a driver of
infertility. Detecting similar numbers of gains and losses within
differentially methylated positions rules out the possibility of
unidirectional methylation changes, the converse of the global
hypomethylation observed in other germ cell-related pathological
diseases such as seminoma [39]. Interestingly, in agreement with
our results, some of the SpF-hypermethylated genes were
previously found hypermethylated in DNA from semen with poor
sperm concentration (i.e. SFN gene and the maternally imprinted
genes PLAGL1 and DIRAS3) [22]. The SCO specimens exhibited a
different profile of methylation compared with control and SpF
samples. This could reflect the distinct sample compositions,
whereby SCO samples almost exclusively contained somatic cells,
whereas SpF samples showed impaired spermatogenesis and germ
cells still present. However, we need to bear in mind that
additional phenotypic changes related to somatic cells are
observed in SCO, such as a greater number of Sertoli cells
(Table 1). Thus, an aberrant pattern of methylation associated
with this extremely severe phenotype of secretory infertility could
not be ruled out.
Among the genes that are hypermethylated in the SpF
phenotype, genes that encode PIWI family members and their
associated proteins involved in piRNA processing such as
PIWIL1/2, TDRD1/9 were able to cluster normal tissue and
patient samples separately. These results and the fact that
impaired expression of these genes leads to sterility in animal
mouse models [26–28] encouraged us to analyze this subgroup of
genes in more detail. We identified and confirmed that PIWIL2
and TDRD1 were hypermethylated in SpF specimens. The
Figure 5. Downregulation of PIWIL2 and TDRD1 is associated with piRNA reduction and LINE-1 hypomethylation. (A–E) Expression
levels of selected piRNAs in testis with conserved spermatogenesis (CS), spermatogenic failure (SpF), Sertoli cell-only syndrome (SCO) phenotypes,
measured by qPCR. Expression levels relative to RNU48, RNU19 and RNU6B are shown. (F) Methylation profiling of LINE-1 in mature spermatozoa
(sperm), testis with conserved spermatogenesis (CS), spermatogenic failure (SpF), Sertoli cell-only syndrome (SCO) phenotypes and somatic tissue,
measured by pyrosequencing. Significant differences from the control are indicated: *p,0.05; **p,0.01. Mean expression levels are depicted by
horizontal bars.
doi:10.1371/journal.pone.0047892.g005
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increase in methylation in SpF patients could be partially
explained by the increase proportion of somatic cells in the
samples but interestingly, an additional statistically significant
increase in the methylation level of germ cells was observed (Fig. 3
and F) in SpF subphenotypes when compared to CS samples,
being more pronounced in the sgMF subphenotype. The gain in
methylation was shown to be significantly correlated with lower
PIWIL2 and TDRD1 expression level analyzing the entire tissue
and more importantly the expression per cell. The remarkable
correlation coefficient between the PIWIL2 transcript levels per
cell and the number of elongated spermatids in the testicular
tubule additionally underlines the determinant role of PIWIL2
expression in the progression of the spermatogenic process.
Moreover, its potential use as a surrogate marker for the presence
of full spermatogenesis in severe non-obstructive infertile patients
should be additionally considered.
The abnormal methylation of PIWIL2, but not of PIWIL1, in
spermatogenic impairment suggests that proper methylation is
essential in the early stages of spermatogenesis. PIWIL2 has been
described as being expressed in the germline during early
spermatogenesis [40,41]. However, PIWIL1 is expressed after
birth in pachytene spermatocytes and spermatids and has been
posited to act in translational control in the latest stages of
spermatogenesis [25]. There is further evidence that PIWIL2 has
essential roles in the initial phases of spermatogenesis: transposon
silencing in fetal gonocytes [42], germline stem cell self-renewal
[40] and early prophase of meiosis [26] in mammalian testis.
Furthermore, PIWIL2 has been implicated in translational
regulation of many genes during early spermatogenesis since it
binds piRNAs and mRNAs [40,43].
TDRD1 interacts directly with both PIWIL2 and PIWIL1 [44].
Although it does not affect the ability of PIWI proteins to associate
with piRNAs in embryonic testes, it ensures the entry of correct
transcripts into the normal piRNA pool [28].
The importance of PIWIL2 and TDRD1 in the efficient
production of mature spermatocytes was previously reported in a
model system using homozygous knock-out mice [26–28].
Interestingly, both recombinant mouse models revealed a common
phenotype: a defect in early prophase of the first meiosis in the
spermatogenesis resulting in sterility. Concordantly, our study
reveals a remarkable and significant negative correlation between
PIWIL2 and TDRD1 methylation and the number of cells from the
earliest steps of spermatogenesis, spermatogoniae and spermato-
cytes. Although still significant, the degree of correlation was lower
for postmeiotic germ cells, suggesting a weaker linear relationship
between PIWIL2 and TDRD1 methylation and the latest stages of
the spermatogenic process. The number of germ cells was
positively correlated with PIWIL2 and TDRD1 expression in the
whole tissue and with PIWIL2 and TDRD1 expression per cell.
Taken together, these results suggest the involvement of PIWIL2
and TDRD1 in the human germ cell development process. We
suggest that DNA hypermethylation in the promoter regions of
PIWIL2 and TDRD1 leads to the transcriptional repression of
these genes contributing to spermatogenic derangement.
Moreover, as PIWIL2 and TDRD1 physically and functionally
interact in the biogenesis of piRNAs, a crucial role of these 26–
31 nt small RNAs in spermatogenesis may be suspected. We
identified a downregulation of mature piRNAs in SpF samples,
similarly to what was described in fetal germ cells of the Mili null
model [42]. The most immediate functional consequence of
piRNA depletion is a derepression of repetitive elements [45–47].
Whether this leads directly to maturation arrest in spermatogenesis
or additional functions of piRNAs and whether associated
complexes contribute to the severe phenotype is currently being
investigated. The repression of PIWIL2 and TDRD1 gene
expression in the severe spermatogenic defects examined in this
study, leads us to speculate that the molecular alterations affecting
piRNAs and their machinery are involved in human infertility.
The aberrant methylation and expression of PIWI-family genes
has the ability to provoke methylation changes of additional loci.
Genetic and molecular characterization identified interactions
between methyltransferases and piRNA pathway members. The
PIWI/DNMT3L complex targets genomic loci, sequence-guided
by small RNAs [48]. DNMT3L [48] as well as PIWIL2 [49] and
TDRD1 [28] null models revealed a loss of methylation at LINE-1
and intracisternal A-particle (IAP) transposons, leading to reacti-
vation of repetitive elements that contribute to meiotic arrest and
male infertility. Consistently, we detected several SpF samples with
hypomethylated LINE-1 sequences, suggesting that reactivation of
transposons also participates in the human spermatogenic failure.
The activation of retrotransposons affects meiotic and premeiotic
germ cells, but not the later stages of spermatogenesis. Interest-
ingly, LINE-1 methylation was only affected in sgMF and scMF
samples, but not in rsMF, where the number of spermatocytes was
similar to that in normal testis. This is consistent with the
assumption that meiotic spermatocytes are protected against
retrotransposons.
In addition to repetitive elements, single genomic loci are also
targeted by PIWI complexes sequence-guided by piRNAs [50].
Here, we identified seven differentially methylated genes in SpF
samples with complementary sequences to piRNAs. Taking into
account that piRNA-guided binding of the PIWI complex has the
ability to alter DNA methylation, we hypothesize that the
differentially methylated promoters containing piRNAs binding
sites are directly affected by the altered expression of PIWIL2 and
TDRD1 in SpF.
In summary, we identified not only an aberrant DNA
methylation profile at CpG sites in male infertility of testicular
origin, but also DNA methylation changes in germline-specific
genes, in particular PIWIL2 and TDRD1, with functional
consequences such as loss of DNA methylation in repetitive
elements and a defective production of piRNAs. Therefore, we
propose that DNA methylation, at least that affecting PIWIL2/
TDRD1, plays a role in the control of human spermatogenic gene
expression, and this process critically contributes to a successful
germ cell development.
Supporting Information
Figure S1 Bisulfite sequencing of PIWIL1 and PIWIL2 in
testis with conserved spermatogenesis (CS), maturation
failure at the spermatocyte (scMF) or at the round
spermatid (rsMF) stage, and with Sertoli cell-only
syndrome (SCO). Black and white squares indicate CpG
methylation and unmethylated sites, respectively. Sample numbers
are indicated.
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Figure S2 Bisulfite sequencing of TDRD1 and TDRD9 in
testis with conserved spermatogenesis (CS), maturation
failure at the spermatocyte (scMF) or at the round
spermatid (rsMF) stage, and with Sertoli cell-only
syndrome (SCO). Black and white squares indicate CpG
methylation and unmethylated sites, respectively. Sample numbers
are indicated.
(PDF)
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